PDA Technical Report 82 (TR 82), "Low Endotoxin Recovery," provides a crucial, internationally recognized framework for managing endotoxin masking in biologic drugs, specifically guiding Hold Time Studies. The 2019 report addresses how formulation components, such as surfactants, can inhibit LAL test detection, with active industry discussions ongoing regarding a future revision. For more details on the upcoming workshop, visit Parenteral Drug Association PDA Pharmaceutical Manufacturing & Quality Conference 2025
However, “PDA Technical Report 82” is not a globally standard or uniquely identifiable document title. Several possibilities exist: pda technical report 82
This report provides a science-based framework for understanding, detecting, and mitigating Low Endotoxin Recovery (LER)—a masking effect that can prevent the reliable detection of endotoxins in biologics. PDA Technical Report 82 (TR 82), "Low Endotoxin
Understanding PDA Technical Report 82: A Guide to Low Endotoxin Recovery (LER) PDA Technical Report 82 (TR 82)